DigitalOcean Indefinite-Lived Research and Development Assets decreased by 22.8% to $34.54M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 22.8%, from $44.72M to $34.54M. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates aggressive investment in external innovation, while a decrease may signal project completion, commercialization, or impairment charges.
This represents the value of acquired in-process research and development (IPR&D) projects that have not yet reached com...
Common in pharmaceutical and medical device sectors where M&A is a primary driver of R&D pipelines.
indefinite_lived_rd_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $0.00 | $32.37M | $30.92M | $44.72M | $34.54M |
| QoQ Change | — | — | -4.5% | +44.7% | -22.8% |
| YoY Change | — | — | -4.5% | +44.7% | -22.8% |